One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2018-99-115252
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 28 |
Affiliation: University of Amsterdam, Academic Medical Center, University of Sydney, Royal Prince Alfred Hospital, University Hospital Cologne, University of Kansas Medical Center, University of Minnesota, Hokkaido University, Novartis (Switzerland), Oregon Health & Science University, Medical University of Vienna, The University of Texas MD Anderson Cancer Center, Claude Bernard University Lyon 1, Hospices Civils de Lyon, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The Ohio State University, James Cancer Hospital, Hôpital Maisonneuve-Rosemont, Université de Montréal, University of Pennsylvania, UPMC Hillman Cancer Center, University of Chicago, Tokyo National Hospital, St Vincent's Hospital, Peter MacCallum Cancer Centre, University of Melbourne, Juravinski Hospital, McMaster University, Tris Pharma (United States), Emory University, Kyushu University, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Oslo University Hospital, New York Hospital Queens, Presbyterian Hospital, Cornell University, NewYork–Presbyterian Hospital, University of WürzburgSustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
